Cystoid Macular Edema: Clinical Trials

4 trials for Cystoid Macular Edema, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated, 1 unknown, 1 withdrawn. 4 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Completed 1, Terminated 1, Unknown 1, Withdrawn 1
Phase 21Unknown 1

Follow Cystoid Macular Edema: new trials by email Literature Review of Cystoid Macular Edema trials Research Report on Cystoid Macular Edema

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Results of Suprachoroidal Steroids Injections in Two Chorioretinal Diseases
Triamcinolone Acetonide - Central Serous Chorioretinopathy, Irvine-Gass Syndrome
Phase 2 / Phase 3UnknownBenha University502022-04-142022-04-20
Effectiveness of Periocular Drug Injection in CATaract Surgery
Bromfenac, Dexamethasone, Triamcinolone Acetonide - Macular Edema, Cystoid Macular Edema
Phase 3TerminatedLuigi Rondas6282021-10-132024-11-04
PRevention of Macular EDema After Cataract Surgery
Bromfenac, Dexamethasone, Bevacizumab - Cystoid Macular Edema, Cataract
Phase 3CompletedMaastricht University Medical Center11272013-07-102017-04-14
Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)
Bevacizumab - Cystoid Macular Edema
Phase 3WithdrawnAsociación para Evitar la Ceguera en México2006-11-012024-06-05

Narrower conditions

Macular Edema (4)  ·  Cataract (2)  ·  Central Serous Chorioretinopathy (1)  ·  Diabetes Mellitus (1)  ·  Eye Diseases (1)  ·  Lens Diseases (1)  ·  Pars Planitis (1)  ·  Retinal Diseases (1)

Broader conditions

Macular Degeneration (4)  ·  Retinal Degeneration (4)  ·  Eye Diseases (3)  ·  Retinal Diseases (3)  ·  Choroid Diseases (1)  ·  Choroiditis (1)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Lens Diseases (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Panuveitis (1)  ·  Uveal Diseases (1)  ·  Uveitis (1)  ·  Uveitis, Intermediate (1)

Interventions

Triamcinolone Acetonide (3)  ·  Bevacizumab (2)  ·  Dexamethasone (2)  ·  Triamcinolone (2)  ·  bromfenac (2)

Sponsors

Asociación para Evitar la Ceguera en México (1)  ·  Benha University (1)  ·  Luigi Rondas (1)  ·  Maastricht University Medical Center (1)

Countries

Austria (2)  ·  Germany (2)  ·  Netherlands (2)  ·  Portugal (2)  ·  Belgium (1)  ·  Egypt (1)  ·  Hungary (1)  ·  Mexico (1)  ·  Spain (1)

Top investigators

Ahmed A Abdelshafy, MD (1)  ·  Nienke Visser, Dr. (1)  ·  Victoria Cubas-Lorenzo, MD (1)  ·  prof. Rudy MM Nuijts, MD, PhD (1)

Results publications

PMID 33009281, PMID 34417781

NIH funding

2019 (1)